Über uns
Association

The Association

Interpharma is the association of research-based pharmaceutical companies in Switzerland and was founded in 1933 as an association based in Basel.

Historically, Interpharma was founded by the major Swiss research-based pharmaceutical companies. With the opening up of the industry in recent years and the associated sharp rise in membership to 23 research-based pharmaceutical companies today, Interpharma has developed into the umbrella organisation for research-based pharmaceutical companies in Switzerland. Its broad support throughout Switzerland strengthens Interpharma’s position in promoting the international competitiveness of Switzerland as a centre for research and pharmaceuticals. Interpharma works closely with all stakeholders in the Swiss healthcare system and international organisations, in particular with interest groups representing the research-based pharmaceutical industry in Switzerland and abroad.

Our Vision

We are the driving force behind an efficient, high-quality healthcare sector that provides patients with rapid access to innovative therapies and the best possible treatments. In Switzerland and abroad, we promote an environment that delivers best-in-class healthcare to patients, rewards innovation and allows our industry to significantly contribute to Switzerland’s prosperity, growth and competitiveness.

Smiling boy wearing headphones in a hospital bed making a victory sign

Our Mission

We represent stakeholders and are committed to a regulatory environment that promotes innovation in Switzerland and abroad while paving the way for pharmaceutical research and development.

We engage as active partners with all stakeholders in the healthcare system to provide solution-oriented outcomes, ensuring quality alongside sustainable and universal patient access to innovation.

We are active contributors to the development of a social, economic and political framework designed to strengthen Switzerland as a pharmaceutical hub.

Membership

As a member of the international industry associations European Federation of Pharmaceutical Industries and Associations (EFPIA) and International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Interpharma is part of a global network of leading research companies. Collaboration within these organisations strengthens international exchange and promotes high standards of innovation and ethics.

This may be of interest to you

Titelbild der Interpharma-Strategie «Pharma Hub Switzerland 2030» (englische Ausgabe)

Pharma hub 2030

Vision for Switzerland as a pharma hub in 2030: «Switzerland is still Europe’s leading pharma hub in 2030. It benefits from high-quality medical innovation and is able to fund this innovation in the long run and sustainably. The pharmaceutical industry is a key contributor to the prosperity and quality of life of people in Switzerland.»

PDF German

PDF French

PDF English

Researcher wearing a cap and face mask working in a laboratory

Key topics

Interpharma is committed to strong pharmaceutical research, Switzerland as an innovative location and an efficient healthcare system – with the aim of ensuring that patients have access to effective therapies.

Doctor examining an elderly female patient in a hospital room

Patient Value

We are committed to ensuring that everyone in Switzerland has access as quickly as possible to safe, effective therapies of the highest possible quality.

Learn more

Researcher at a microscope with test tubes

Research and Development

We strengthen Switzerland as a hub for innovation: from the idea in the lab to therapy for patients, for medical progress and patient benefit.

Learn more

Medicine vials in pharmaceutical production

Pharma Location Switzerland

Political stability, legal certainty, open export markets and a skilled workforce are key to the success of Switzerland as a pharmaceutical hub.

Learn more

PARTNERSHIPS

An active partner in the health and research environment through cooperation.

Interpharma attaches great importance to promoting broad dialogue on current health and research policy issues and encouraging public debate on relevant questions. Interpharma therefore works with various stakeholders in the health and research sectors, contributing its expertise and supporting organisations and platforms in planning and staging events, developing policy frameworks and other activities. In recognition of the importance of the militia system and the state-supporting role of political parties, Interpharma also supports innovation- and business-friendly parties with a total annual amount of up to CHF 100,000, which is distributed evenly.